Dogwood Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Dogwood Therapeutics, Inc. reported Earnings Per Share Diluted of $7.13 (loss) per share for the year ending 2025.

  • Dogwood Therapeutics, Inc. showed an increase of +43.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Dogwood Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Dogwood Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 239.5%.
  • Historical annual values: Fiscal year 2025: $7.13 (loss) per share | Fiscal year 2024: $12.52 (loss) per share | Fiscal year 2023: $7.05 (loss) per share | Fiscal year 2022: $1.11 (loss) per share | Fiscal year 2021: $1.92 (loss) per share | Fiscal year 2020: $2.10 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: